Ticker >

Medico Remedies share price

Medico Remedies Ltd.

NSE: MEDICO BSE: 540937 SECTOR: Pharmaceuticals & Drugs  19k   50   4

48.10
-2.20 (-4.37%)
NSE: 28 Mar 4:00 PM

Price Summary

Today's High

₹ 50.8

Today's Low

₹ 47.8

52 Week High

₹ 100.7

52 Week Low

₹ 44.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

399.15 Cr.

Enterprise Value

405.07 Cr.

No. of Shares

8.3 Cr.

P/E

57.36

P/B

8.14

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  5.91

CASH

2.18 Cr.

DEBT

8.09 Cr.

Promoter Holding

73.34 %

EPS (TTM)

₹  0.84

Sales Growth

16.04%

ROE

18.01 %

ROCE

21.88%

Profit Growth

50.49 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year16.04%
3 Year16.58%
5 Year18.14%

Profit Growth

1 Year50.49%
3 Year64.38%
5 Year42.78%

ROE%

1 Year18.01%
3 Year13.42%
5 Year10.32%

ROCE %

1 Year21.88%
3 Year15.7%
5 Year12.51%

Debt/Equity

0.1846

Price to Cash Flow

48.87

Interest Cover Ratio

14.5174675411591

CFO/PAT (5 Yr. Avg.)

0.483601635197935

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 73.34 0
Sep 2023 73.34 0
Jun 2023 73.34 0
Mar 2023 73.34 0
Dec 2022 73.34 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 64.3802335385258% for the Past 3 years.
  • The company has shown a good revenue growth of 16.579768902644% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 14.5174675411591.
  • The company has an efficient Cash Conversion Cycle of 15.5253605368135 days.
  • The company has a high promoter holding of 73.34%.

 Limitations

  • The company is trading at a high PE of 57.36.
  • The company is trading at a high EV/EBITDA of 31.7011.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 38.85 27.99 31.47 42.36 29.77
Total Expenditure 35.46 24.83 29.01 39.28 27.04
Operating Profit 3.39 3.16 2.46 3.08 2.73
Other Income 0.86 0.04 0.31 0.96 0.27
Interest 0.2 0.21 0.17 0.18 0.22
Depreciation 0.74 0.73 0.71 0.71 0.72
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.32 2.27 1.88 3.14 2.06
Tax 1.07 0.51 0.56 0.72 0.62
Profit After Tax 2.25 1.77 1.32 2.43 1.45
Adjusted EPS (Rs) 0.05 0.21 0.16 0.29 0.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 97.69 88.64 122.39 121.02 140.44
Total Expenditure 94.93 85.8 117.15 113.69 130.96
Operating Profit 2.76 2.84 5.24 7.33 9.48
Other Income 1.9 2.1 1.03 2.03 4.09
Interest 0.98 1.06 0.92 0.66 0.75
Depreciation 1.51 1.66 1.65 2.22 2.72
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.18 2.22 3.7 6.48 10.1
Tax 0.6 0.58 1.11 1.67 2.86
Net Profit 1.57 1.63 2.59 4.81 7.24
Adjusted EPS (Rs.) 0.19 0.2 0.31 0.58 0.87

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 4.15 4.15 4.15 16.6 16.6
Total Reserves 24.09 25.72 28.31 19.98 27.25
Borrowings 2.37 4.71 4.95 0.9 0.25
Other N/C liabilities 0.25 0.22 0.26 1.6 1.84
Current liabilities 45.45 40.48 37.95 39.57 43.15
Total Liabilities 76.31 75.27 75.62 78.65 89.08
Assets
Net Block 12.27 12.55 15.31 18.03 21.83
Capital WIP 0.9 2.28 0 0 0
Intangible WIP 0 0 0 0 0.07
Investments 0.15 0.15 0.11 0 0
Loans & Advances 3.77 3.59 1.72 1.54 0.85
Other N/C Assets 0.05 0.06 0 0.07 0.16
Current Assets 59.18 56.64 58.48 59.01 66.17
Total Assets 76.31 75.27 75.62 78.65 89.08
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 2.18 2.22 3.68 6.48 10.1
Adjustment 1.86 2.14 2.57 2.52 2.71
Changes in Assets & Liabilities 1.49 -2.81 -16.63 -1.34 -2.15
Tax Paid -0.55 -0.54 -0.93 -1.79 -2.5
Operating Cash Flow 4.94 0.97 -11.31 5.86 8.17
Investing Cash Flow -4.43 -3.08 -16.96 -1.76 -6.6
Financing Cash Flow -0.55 2.6 18.28 -5.77 -1.82
Net Cash Flow -0.04 0.48 -9.99 -1.67 -0.25

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 73.34 73.34 73.34 73.34 73.34
haresh kapurlal mehta 16.56 16.56 16.56 16.56 28.45
harshit h mehta huf 0.87 0.87 0.87 0.87 0.87
harshit haresh mehta 9.11 9.11 9.11 9.11 9.11
priyal rishit mehta 6.27 6.27 6.27 6.27 6.27
rishit hareshbhai mehta 9.49 9.49 9.49 9.49 9.49
rita h mehta 10.40 10.40 10.40 10.40 10.40
shweta harshit mehta 8.75 8.75 8.75 8.75 8.75
haresh k mehta huf 11.90 11.90 11.90 11.90 -
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 26.66 26.66 26.66 26.66 26.66
escorp asset management l... 1.78 1.78 1.78 1.78 1.78
kanchan rani - - - 1.33 1.33
moneyplant gold & jewelle... - - - - 1.20
nopea capital services pr... 2.21 2.21 2.21 1.90 1.90
ravi goyal huf - - - 1.77 1.92
sanjay narendra bansal 1.50 1.50 1.50 1.50 1.50
vijaygopal parasram atal 2.08 2.08 2.08 2.08 2.08
emrald commercial limited... 2.50 2.07 2.07 2.07 -
s k growth fund pvt ltd 2.72 2.42 1.33 1.09 -
kaushik mahesh waghela - - 1.01 - -
venkateshwara industrial ... 2.40 1.50 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

  • PresentationQ2FY24 15 Jan 2024

Company News

Medico Remedies - Quaterly Results12 Feb 2024, 4:29PM Medico Remedies - Quaterly Results12 Feb 2024, 4:29PM Medico Remedies - Quaterly Results12 Feb 2024, 4:29PM Medico Remedies informs about investor presentation11 Jan 2024, 2:46PM Medico Remedies informs about disclosure 3 Nov 2023, 12:42PM Medico Remedies submits intimation of cancellation of inter-se transfer of shares 23 Oct 2023, 2:53PM Medico Remedies informs about newspaper publication11 Aug 2023, 1:50PM Medico Remedies - Quaterly Results10 Aug 2023, 3:49PM Medico Remedies - Quaterly Results10 Aug 2023, 3:49PM Medico Remedies informs about newspaper publication24 Jul 2023, 12:41PM Medico Remedies informs about press release21 Jul 2023, 12:13PM Medico Remedies to foray into ointment manufacturing segment 15 May 2023, 9:29AM Medico Remedies - Quaterly Results11 May 2023, 7:56PM Medico Remedies - Quaterly Results11 May 2023, 7:56PM Medico Remedies submits board meeting intimation 3 May 2023, 4:49PM Medico Remedies - Quaterly Results10 Feb 2023, 5:23PM Medico Remedies - Quaterly Results10 Feb 2023, 5:23PM Medico Remedies informs about board meeting14 Jan 2023, 11:22AM Medico Remedies informs about trading window closure27 Dec 2022, 3:02PM Medico Remedies - Quaterly Results12 Nov 2022, 9:24PM Medico Remedies informs about newspaper advertisement30 Aug 2022, 4:52PM Medico Remedies informs about RPT disclosures16 Aug 2022, 4:28PM Medico Remedies informs about board meeting12 May 2022, 5:08PM Medico Remedies submits 27th AGM notice8 Sep 2021, 4:19PM Medico Remedies informs about revised disclosure2 Jun 2021, 2:03PM Medico Remedies informs about disclosure21 Apr 2021, 12:51PM Medico Remedies informs about disclosure21 Apr 2021, 12:19PM

Medico Remedies Stock Price Analysis and Quick Research Report. Is Medico Remedies an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Medico Remedies and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Medico Remedies cash from the operating activity was Rs 8.1672 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Medico Remedies has a Debt to Equity ratio of 0.1846 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Medico Remedies , the EPS growth was 50.4742196930505 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Medico Remedies has OPM of 6.75112185215619 % which is a bad sign for profitability.
     
  • ROE: Medico Remedies have a average ROE of 18.0097391615766 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Medico Remedies is Rs 48.1. One can use valuation calculators of ticker to know if Medico Remedies share price is undervalued or overvalued.
Last Updated on:
Brief about Medico Remedies
X